Diseases, Conditions, Syndromes

T-cells with a license to kill viruses

A research group led by Kyoto University has produced the world's first pluripotent stem cell-derived killer T-cell drug to treat COVID-19. The University has filed a patent application ahead of full-scale drug development.

Health informatics

Physicians' role crucial in using AI in patient care, say experts

Artificial intelligence is quickly transforming the health care landscape from helping to diagnose diseases to assisting in surgery. Its rapid progression has the potential to transform how health care teams work by streamlining ...

Oncology & Cancer

Researchers uncover how colorectal cancer cells colonize the liver

In cases where cancer is fatal, 9 out of 10 times the culprit is metastasis. This is when the primary tumor has sent out cells, like seeds, and invaded other organs of the body. While medicine has made great progress in treating ...

page 1 from 40